$VICR

VINCIARELLI PATRIZIO sold $659K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 2,026 shares of VICOR CORP (VICR) at $325.19 ($0.66M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 2, 2026, 7:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 7:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it is generally treated as non-informational; the main tradable element is potential short-term sentiment/positioning around the disclosure.

02

Market read

Routine insider selling disclosure with limited fundamental implications; watch for any follow-on insider activity or concurrent company-specific news.

03

What to watch

The article doesn’t state whether the sale is part of a larger multi-tranche program, nor does it compare to prior insider activity or total insider ownership changes beyond the post-trade figure.

Relevance 7/10Novelty 4/10Timing: Filed today; sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction by VICR’s Chairman/CEO, including execution details and confirmation of a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s Chairman/CEO sold 2,026 shares in an open-market transaction for ~$658.8K, disclosed via SEC Form 4.

Expected impact

Likely limited/short-lived impact; any move would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing specifies an open-market sale and a pre-arranged 10b5-1 plan, which reduces the likelihood of information leakage; the article provides no new operating/financial catalyst.

Market effects

Minimal—single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated or sizable insider selling can be read by some traders as reduced confidence, especially if it coincides with other negative signals.

Key entities

  • VICOR CORP

    Subject of the insider transaction disclosure; Chairman/CEO sold shares via open-market sale under a 10b5-1 plan.

  • VINCIARELLI PATRIZIO

    Chairman and CEO (also officer/director/10% owner) who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MXLHighAI 8/10

MXL vs. VICR: Which Has the Better AI Infrastructure Opportunity?

MaxLinear (MXL) and Vicor (VICR) are positioned to benefit from AI infrastructure growth. MXL reported 55% revenue growth in Q2 2026, driven by optical and electrical interconnects. Vicor focuses on power delivery for AI processors. MXL's AI products, like Keystone and Rushmore, are in high demand, with new products expected to launch in 2027 and 2028.

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: